A Site Built for Amoxicillin-Clavulanate

Finecure operates a dedicated site principally producing amoxicillin-clavulanate and amoxicillin. Clavulanate is among the most moisture-sensitive molecules in common manufacture, and the facility is engineered for it: a 100% physically isolated block with independent HVAC held below 20% relative humidity, and no shared oral solid lines.

The plant produces the full range – capsules, tablets, dispersible tablets and dry syrup – across paediatric and adult strengths. Amoxicillin-clavulanate tablets and powder for oral suspension are supplied to IP, USP and BP specification; the dispersible presentation to IP and BP. Specification is stated per presentation on each product page rather than claimed across the range.

For P2P partners, supply is available from the same block that produces Finecure’s own branded range, with stability data available for ICH Zones II, IVa and IVb.